| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $13,308,479 | 22 | 100 |
| TORRES ARTHUR A | director | 0 | $0 | 2 | $214,676 | $-214,676 |
| Novack Jeffrey Adam | Secretary and General Counsel | 0 | $0 | 5 | $452,744 | $-452,744 |
| COURNOYER CHRISTINE | director | 0 | $0 | 1 | $750,973 | $-750,973 |
| Bickerstaff George | director | 0 | $0 | 1 | $925,700 | $-925,700 |
| Valantine Hannah | director | 0 | $0 | 2 | $1.32M | $-1.32M |
| Goldberg Michael | director | 0 | $0 | 1 | $2.1M | $-2.1M |
| Hanna John Walter JR | President and CEO | 0 | $0 | 10 | $7.54M | $-7.54M |
CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their healthcare providers. The company's extensive portfolio features a range of specialized diagnostic solutions for organ monitoring, including: AlloSure Kidney, AlloSure Heart, and AlloSure Lung: Advanced tests employing donor-derived cell-free DNA (dd-cfDNA) technology to assess the health of kidney, heart, and lung transplants, respectively. AlloMap Heart: A gene …
Over the last 12 months, insiders at CareDx, Inc have bought $0 and sold $13.31M worth of CareDx, Inc stock.
On average, over the past 5 years, insiders at CareDx, Inc have bought $240,266 and sold $5.35M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $211,694 was made by Dhingra Ankur (Chief Financial Officer) on 2021‑11‑24.
| 2026-08-05 | Sale | Bickerstaff George | director | 20,000 0.0393% | $46.28 | $925,700 | +19.36% | |
| 2026-08-05 | Sale | Novack Jeffrey Adam | Secretary and General Counsel | 2,688 0.0053% | $46.26 | $124,349 | +19.36% | |
| 2026-08-04 | Sale | Goldberg Michael | director | 44,700 0.0863% | $47.06 | $2.1M | +15.30% | |
| 2026-08-04 | Sale | COURNOYER CHRISTINE | director | 16,000 0.0308% | $46.94 | $750,973 | +15.30% | |
| 2026-07-16 | Sale | Hanna John Walter JR | President and CEO | 118,000 0.214% | $37.79 | $4.46M | +26.33% | |
| 2026-07-16 | Sale | Valantine Hannah | director | 28,779 0.0499% | $36.15 | $1.04M | +26.33% | |
| 2026-06-29 | Sale | Hanna John Walter JR | President and CEO | 39,900 0.0771% | $29.24 | $1.17M | +70.87% | |
| 2026-06-26 | Sale | Hanna John Walter JR | President and CEO | 100 0.0002% | $29.00 | $2,900 | +73.58% | |
| 2026-06-15 | Sale | Hanna John Walter JR | President and CEO | 17,683 0.0342% | $24.03 | $424,877 | +104.67% | |
| 2026-06-15 | Sale | Valantine Hannah | director | 12,103 0.0225% | $23.11 | $279,728 | +104.67% | |
| 2026-06-11 | Sale | Hanna John Walter JR | President and CEO | 21,998 0.0432% | $24.02 | $528,443 | +106.21% | |
| 2026-06-04 | Sale | Hanna John Walter JR | President and CEO | 4,835 0.0097% | $24.00 | $116,045 | +105.45% | |
| 2026-05-15 | Sale | TORRES ARTHUR A | director | 6,484 0.0125% | $19.89 | $128,978 | +134.55% | |
| 2026-05-14 | Sale | TORRES ARTHUR A | director | 4,086 0.0081% | $20.97 | $85,698 | +127.87% | |
| 2026-05-05 | Sale | Novack Jeffrey Adam | Secretary and General Counsel | 2,688 0.0052% | $20.68 | $55,581 | +121.45% | |
| 2026-04-16 | Sale | Hanna John Walter JR | President and CEO | 10,282 0.0188% | $21.12 | $217,156 | +71.90% | |
| 2026-02-03 | Sale | Novack Jeffrey Adam | Secretary and General Counsel | 4,441 0.0086% | $20.56 | $91,286 | +21.76% | |
| 2026-01-22 | Sale | Hanna John Walter JR | President and CEO | 19,280 0.0377% | $21.16 | $408,023 | +11.70% | |
| 2026-01-21 | Sale | Hanna John Walter JR | President and CEO | 200 0.0004% | $21.00 | $4,200 | +12.67% | |
| 2026-01-15 | Sale | Hanna John Walter JR | President and CEO | 10,156 0.0202% | $21.05 | $213,804 | +13.03% |
| Goldberg Michael | director | 61738 0.1175% | $5.46M | 1 | 13 | <0.0001% |
| TORRES ARTHUR A | director | 38665 0.0736% | $3.42M | 1 | 2 | <0.0001% |
| TPG Group Holdings (SBS) Advisors, Inc. | 10 percent owner | 1075090 2.0461% | $95.11M | 1 | 0 | <0.0001% |
| BYERS BROOK H | 751174 1.4296% | $66.46M | 1 | 0 | <0.0001% | |
| KLEINER PERKINS CAUFIELD & BYERS X A LP | 10 percent owner | 751174 1.4296% | $66.46M | 1 | 0 | <0.0001% |
| Maag Peter | director | 308846 0.5878% | $27.32M | 4 | 58 | +57.09% |
| Gagnon Neil | 10 percent owner | 107940 0.2054% | $9.55M | 48 | 1 | +71.45% |
| Bell Michael Brian | Chief Financial Officer | 103343 0.1967% | $9.14M | 1 | 10 | +288.89% |
| Nelles Mitchell J | Chief Operating Officer | 85160 0.1621% | $7.53M | 1 | 2 | <0.0001% |
| Whitson Todd | Chief Commercial Officer | 10000 0.019% | $884,700.00 | 1 | 0 | <0.0001% |
| LUDLUM KEN | Chief Financial officer | 5000 0.0095% | $442,350.00 | 1 | 0 | <0.0001% |
| Dhingra Ankur | Chief Financial Officer | 5000 0.0095% | $442,350.00 | 1 | 0 | <0.0001% |
| Increased Positions | 105 | +49.3% | 7M | +12.88% |
| Decreased Positions | 90 | -42.25% | 7M | -13.41% |
| New Positions | 44 | New | 2M | New |
| Sold Out Positions | 27 | Sold Out | 1M | Sold Out |
| Total Postitions | 228 | +7.04% | 53M | -0.53% |
| Blackrock, Inc. | $91,239.00 | 9.35% | 4.77M | +108,998 | +2.34% | 2025-09-30 |
| Vanguard Group Inc | $71,769.00 | 7.35% | 3.75M | -1M | -23.64% | 2025-09-30 |
| Bamco Inc /Ny/ | $60,390.00 | 6.19% | 3.16M | +719,523 | +29.54% | 2025-09-30 |
| State Street Corp | $49,122.00 | 5.03% | 2.57M | +386,304 | +17.72% | 2025-09-30 |
| Ophir Asset Management Pty Ltd | $42,069.00 | 4.31% | 2.2M | +304,953 | +16.11% | 2025-09-30 |
| Deerfield Management Company, L.P. | $41,936.00 | 4.3% | 2.19M | +2M | New | 2025-09-30 |
| Braidwell Lp | $41,778.00 | 4.28% | 2.18M | +2M | New | 2025-09-30 |
| Ark Investment Management Llc | $41,546.00 | 4.26% | 2.17M | +70,468 | +3.35% | 2025-09-30 |
| Sumitomo Mitsui Trust Group, Inc. | $33,305.00 | 3.41% | 1.74M | +503,136 | +40.68% | 2025-09-30 |
| Amova Asset Management Americas, Inc. | $33,305.00 | 3.41% | 1.74M | +504,473 | +40.83% | 2025-09-30 |